7 companies owned by American multimillionaire Kneeland Youngblood

Kneeland Youngblood spent his early career in the emergency room. He graduated from Princeton University in 1978 with a degree in politics and science, then earned his medical degree from the University of Texas Southwestern Medical School in 1982. He practiced emergency medicine in Texas before deciding, in the mid-1990s, that the most consequential work he could do in healthcare would happen at the level of capital, not the clinic.

That pivot produced a business life most physicians never imagine. He co-founded Pharos Capital Group in 1998 with a clear thesis: back companies built to change how care was delivered and priced in underserved American communities. Nearly three decades later, Pharos manages $665 million in assets and has backed 61 companies. Along the way, Youngblood has collected board seats at some of the most prominent names in American business, received presidential appointments and built a personal portfolio that stretches from blockchain infrastructure to specialty pharmaceuticals.

These are the seven companies Kneeland Youngblood owns and controls.

The Dallas firm he built from a physician's conviction

At the center of Youngblood's financial life is Pharos Capital Group, the Dallas and Nashville-based private equity firm he co-founded in 1998. He serves as founding partner, chairman and chief executive officer, responsible for overall strategy and investment committee decisions across all of Pharos' funds. The firm focuses on value-based care companies, targeting businesses designed to cut the total cost of healthcare while improving patient access and outcomes. Pharos typically invests between $25 million and $50 million per deal, and has now completed investments in 61 companies since inception.

His first commercial vehicle before Pharos existed

Before Pharos existed, Youngblood set up Youngblood Enterprises, Inc., a Dallas-registered company that served as his initial commercial vehicle in the early 1990s. The firm gave him early exposure to the economics of healthcare consulting and business services, and let him convert his clinical background into market-facing strategy at a time when most physicians remained inside hospital systems. It served as the foundational block from which the larger Pharos platform was eventually built.

A joint venture putting hardware and software financing into the market

Pharos Financial Services is a joint venture with Dell Financial Services that provides financing solutions for computer hardware and software. Youngblood holds a position within this entity as a managing director, giving the broader Pharos platform a presence in the commercial financing space. The venture connects the firm's capital infrastructure with one of the largest technology distribution networks in the world.

Lead director at a gaming company rebuilding itself for the digital era

Youngblood joined the board of what was then Scientific Games in 2018 and now serves as lead director of Light & Wonder, the company's rebranded successor. Listed on both the New York Stock Exchange and the Australian Securities Exchange, Light & Wonder operates in the global gaming and entertainment market, producing cross-platform games and systems. His governance role has been central to the company's shift away from its legacy lottery supply business toward a digital-first gaming strategy.

A former board seat at one of North America's largest computing operators

Youngblood held a board seat at Core Scientific, one of North America's largest high-performance computing operators, with a term that ended in January 2024. During his tenure, the company ran data center infrastructure supporting bitcoin mining and other compute-intensive applications, positioning its operations around carbon-neutral energy sourcing. His involvement reflected an investor comfortable navigating the regulatory and technical complexity of digital infrastructure, a sector far from his medical origins.

A directorship inside the largest leveraged buyout in American history

Formerly known as TXU, Energy Future Holdings was a Texas-based electricity producer at the center of a $45 billion leveraged buyout completed in 2007, one of the largest such transactions in American history. Youngblood served as a director and investor in the company. His broader energy credentials include a Senate-confirmed presidential appointment by Bill Clinton to the board of the United States Enrichment Corporation, where the task was to oversee the privatization of nuclear fuel production.

A specialty pharmaceutical stake built around clinical restructuring

Youngblood has held a directorship and investment stake in Mallinckrodt plc, a specialty pharmaceutical company with operations across branded drugs, generic treatments and hospital imaging agents. His board tenure coincided with a significant period of restructuring and product pipeline shifts at the company. The role fits neatly inside his consistent investment thesis: healthcare businesses operating at the intersection of clinical need, cost reduction and underserved patient access.